ArticlePituitary2026
Pituitary stalk thickening: can a multiparametric MRI approach improve etiologic prediction?
Article in Pituitary, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the diagnostic contribution of MRI-based morphological and signal features-particularly T2-weighted signal intensity-for differentiating the etiology of pituitary stalk thickening (PST), and to develop imaging-based models for predicting inflammatory and neoplastic pathologies.
methodsThis retrospective study included 41 adult (51.2%) and pediatric (48.8%) patients with confirmed PST who underwent contrast-enhanced pituitary MRI between 2012 and 2021. Etiologies were classified as congenital/idiopathic, inflammatory/infectious, or neoplastic based on clinical, radiological, or histopathological criteria. Imaging findings including enhancement pattern and T2 signal intensity were assessed in consensus by two neuroradiologists blinded to clinical data. Statistical analyses included univariate and multivariate logistic regression and receiver operating characteristic (ROC) curve analysis.
resultsNeoplastic lesions were associated with significantly greater stalk thickness (median: 5.9 mm) compared to non-neoplastic lesions (median: 3.83 mm; p = 0.012). T2-weighted hyperintensity was present in 70% of neoplastic lesions, while hypointensity was more frequent in inflammatory/infectious lesions (p = 0.017). A multivariable model incorporating stalk thickness, non-T2 hypointensity and V-shaped enhancement patterns yielded excellent diagnostic performance for neoplastic pathologies (AUC: 0.848; 95% CI: 0.713-0.982). A second model using stalk thickness and T2 hypointensity predicted inflammatory lesions with an AUC of 0.836 (95% CI: 0.715-0.957).
conclusionTo our knowledge, this is the first study to propose MRI-based models using stalk morphology and signal features to predict PST etiology. These non-invasive models, developed without clinical input, demonstrate promising diagnostic accuracy and may aid in differential diagnosis. Further validation in larger cohorts is needed.
Indexed as
Identifiers
41524976What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.